Logo image of M3V.DE

MEVIS MEDICAL SOLUTIONS AG (M3V.DE) Stock Earnings & Estimates

FRA:M3V - DE000A0LBFE4 - Common Stock

25.6 EUR
-0.6 (-2.29%)
Last: 9/4/2025, 7:00:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024
Revenue
YoY % growth
M3V.DE revenue by date.M3V.DE revenue by date.
18.762M
15.71%
17.342M
-7.57%
16.972M
-2.13%
EBITDA
YoY % growth
M3V.DE ebitda by date.M3V.DE ebitda by date.
6.563M
44.42%
5.001M
-23.80%
4.135M
-17.32%
EBIT
YoY % growth
M3V.DE ebit by date.M3V.DE ebit by date.
6.47M
46.41%
4.905M
-24.19%
4.002M
-18.41%
Operating Margin
M3V.DE operating margin by date.M3V.DE operating margin by date.
34.48%28.28%23.58%
EPS
YoY % growth
M3V.DE eps by date.M3V.DE eps by date.
N/AN/AN/A

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
M3V.DE Yearly EPS VS EstimatesM3V.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 1 2 3
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth
8.197M
-7.59%
%
Q2 2024
Q2Q % growth
8.774M
3.56%
%
Q4 2023
Q2Q % growth
8.87M
-13.18%
%
Q2 2023
Q2Q % growth
8.472M
-0.87%
%
Q4 2022
Q2Q % growth
10.216M
25.60%
%
Q2 2022
Q2Q % growth
8.546M
5.77%
%
Q4 2021
Q2Q % growth
8.134M
-3.79%
%
Q2 2021
Q2Q % growth
8.08M
-6.88%
%
Q4 2020
Q2Q % growth
8.454M
-8.69%
%
Q2 2020
Q2Q % growth
8.677M
-1.57%
%
M3V.DE Yearly Revenue VS EstimatesM3V.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A